Takagi, Manami
Maruko, Ichiro
Yamaguchi, Ayane
Kakehashi, Mizuha
Hasegawa, Taiji
Iida, Tomohiro
Article History
Received: 13 October 2018
Revised: 19 March 2019
Accepted: 7 April 2019
First Online: 4 July 2019
Compliance with ethical standards
:
: MT has nothing to disclose. IM reports grants from JSPS KAKENHI (Grant Number JP16K11274), grants and personal fees from Novartis Pharma K.K., personal fees from Bayer Yakuhin, Ltd., personal fees from Santen Pharmaceutical Inc., personal fees from Alcon Japan, Ltd., personal fees from Topcon Co., Ltd., personal fees from Senju Pharmaceutical Co., Ltd., personal fees from NIDEK Co., Ltd., outside the submitted work. Dr. Yamaguchi has nothing to disclose. MK has nothing to disclose. TH has nothing to disclose. TI reports grants and personal fees from Novartis Pharma K.K. (Japan), personal fees from Bayer Yakuhin, Ltd. (Japan), grants and personal fees from Santen Pharmaceutical Co., Ltd. (Japan), grants from Nidek, grants from Kowa, grants and personal fees from Canon, grants and personal fees from Topcon, grants and personal fees from Senju Seiyaku, grants from AMO, grants and personal fees from JFC, outside the submitted work. The remaining author declares that she has no conflict of interest.